Market Overview:
The global chromhidrosis treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chromhidrosis, rising awareness about chromhidrosis, and technological advancements in the field of chromhidrosis treatment. The global chromhidrosis treatment market is segmented on the basis of type, application, and region. On the basis of type, it is divided into apocrine chromhidrosis, eccrine chromhidrosis, and pseudochromidrosis. On the basis of application, it is classified into hospitals and clinics, specialty and dermatology clinics,,and others. Geographically,,the market is analyzed across North America,,Latin America,,Europe,,Asia Pacific.,and Middle East & Africa. Some key players operating in this market are Syneron Medical Ltd., Lumenis Ltd., Cutera Inc., Alma Lasers Ltd., Solta Medical Inc.
Product Definition:
Chromhidrosis is a condition that causes the skin to sweat excessively and release abnormal colors. The most common colors are yellow, green, and blue. Chromhidrosis can be treated with medications such as anticholinergics or botox.
Apocrine Chromhidrosis:
Apocrine chromhidrosis is a rare disease that affects the apocrine glands of the body. These are usually found in women and can cause major health issues like skin lesions, odor, and breast cancer. The disease has different types such as localized (in situ), non-localized ( generalized) & others.
Eccrine Chromhidrosis:
Eccrine chromhidrosis is the most common type of body odor disorder. It is a rare condition affecting less than one in a million people. The exact cause of this disease is unknown, but it may be genetic and may also be triggered by certain medications or medical conditions such as diabetes mellitus, hyperthyroidism, Parkinson’s disease or other neurological disorders.
The symptoms associated with this disease are excessive sweating.
Application Insights:
The others segment held the largest market share in 2017 and is anticipated to grow at a lucrative CAGR during the forecast period. Other applications of chromhidrosis treatment include hospitals and clinics, specialty clinics, home care, and dermatology offices. Hospitals are considered to be the most effective places for treating chromhidrosis as they offer thermal clothing and specialized equipment for patients who come with excessive body sweat patches or other symptoms of hyperhidrosis. Chromhidroasis can also be effectively treated in clinics that provide isolation rooms for patients along with antiperspirants or deodorants that help control excessive sweating.
Specialty dermatology clinics have been found more effective than general physicians' offices regarding managing cases related to Eccrine (glands) or apocrine (sweat) chromhidrosis due to their greater experience in handling such conditions along with access to advanced equipment such as heat lamps and cooling devices which are not available at walk-in medical centers or primary care doctors' offices.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in chromhidrosis cases, high disposable income, and availability of effective treatment methods. In addition, an increase in awareness about various available treatments is also expected to drive the regional market over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to increasing healthcare expenditure by governments and private sectors as well as growing patient awareness levels regarding various available treatment options for chromhidrosis. Moreover, rising number of research studies on new drug development for treating chromhidrosis will further boost growth prospects during the forecast years.
Growth Factors:
- Increasing awareness about chromhidrosis and its treatment options among people.
- Growing demand for minimally invasive procedures for the treatment of chromhidrosis.
- Rising number of clinical studies on the efficacy of various chromhidrosis treatments.
- increasing investment by private players and research institutes in chromhidrosis research and development activities .
Scope Of The Report
Report Attributes
Report Details
Report Title
Chromhidrosis Treatment Market Research Report
By Type
Apocrine Chromhidrosis, Eccrine Chromhidrosis, Pseudochromhidrosis
By Application
Hospitals and Clinics, Specialty and Dermatology Clinics, Others
By Companies
Ipsen Pharma, Medytox, Revence Therapeutics, Inc., ALLERGAN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Chromhidrosis Treatment Market Report Segments:
The global Chromhidrosis Treatment market is segmented on the basis of:
Types
Apocrine Chromhidrosis, Eccrine Chromhidrosis, Pseudochromhidrosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Specialty and Dermatology Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ipsen Pharma
- Medytox
- Revence Therapeutics, Inc.
- ALLERGAN
Highlights of The Chromhidrosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Apocrine Chromhidrosis
- Eccrine Chromhidrosis
- Pseudochromhidrosis
- By Application:
- Hospitals and Clinics
- Specialty and Dermatology Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chromhidrosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chromhidrosis is a skin condition that results from excessive production of sweat. The sweat contains large amounts of salt and other minerals, which causes the skin to become irritated and red. Treatment typically involves using topical medications to reduce sweating, wearing clothing that traps less sweat, and avoiding hot environments.
Some of the major players in the chromhidrosis treatment market are Ipsen Pharma, Medytox, Revence Therapeutics, Inc., ALLERGAN.
The chromhidrosis treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chromhidrosis Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Chromhidrosis Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Chromhidrosis Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Chromhidrosis Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Chromhidrosis Treatment Market Size & Forecast, 2018-2028 4.5.1 Chromhidrosis Treatment Market Size and Y-o-Y Growth 4.5.2 Chromhidrosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Chromhidrosis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chromhidrosis Treatment Market Size Forecast by Type
5.2.1 Apocrine Chromhidrosis
5.2.2 Eccrine Chromhidrosis
5.2.3 Pseudochromhidrosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chromhidrosis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chromhidrosis Treatment Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Specialty and Dermatology Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chromhidrosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chromhidrosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chromhidrosis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Chromhidrosis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chromhidrosis Treatment Market Size Forecast by Type
9.6.1 Apocrine Chromhidrosis
9.6.2 Eccrine Chromhidrosis
9.6.3 Pseudochromhidrosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chromhidrosis Treatment Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Specialty and Dermatology Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chromhidrosis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Chromhidrosis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chromhidrosis Treatment Market Size Forecast by Type
10.6.1 Apocrine Chromhidrosis
10.6.2 Eccrine Chromhidrosis
10.6.3 Pseudochromhidrosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chromhidrosis Treatment Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Specialty and Dermatology Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chromhidrosis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chromhidrosis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chromhidrosis Treatment Market Size Forecast by Type
11.6.1 Apocrine Chromhidrosis
11.6.2 Eccrine Chromhidrosis
11.6.3 Pseudochromhidrosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chromhidrosis Treatment Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Specialty and Dermatology Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chromhidrosis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Chromhidrosis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chromhidrosis Treatment Market Size Forecast by Type
12.6.1 Apocrine Chromhidrosis
12.6.2 Eccrine Chromhidrosis
12.6.3 Pseudochromhidrosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chromhidrosis Treatment Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Specialty and Dermatology Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chromhidrosis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chromhidrosis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chromhidrosis Treatment Market Size Forecast by Type
13.6.1 Apocrine Chromhidrosis
13.6.2 Eccrine Chromhidrosis
13.6.3 Pseudochromhidrosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chromhidrosis Treatment Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Specialty and Dermatology Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chromhidrosis Treatment Market: Competitive Dashboard
14.2 Global Chromhidrosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ipsen Pharma
14.3.2 Medytox
14.3.3 Revence Therapeutics, Inc.
14.3.4 ALLERGAN